最新的帖子

一月 21, 2021

West's Envision™ Verification System – Risk Mitigation for Quality of Drug Product

One factor of parenteral drug product quality is the container closure integrity (CCI) of the primary packaging system. The interaction between the sealing surface of the elastomeric component and the vial is vital to ensure stability of the drug product over the shelf life. Therefore, defects found on the elastomeric component can increase the risk of failure or end-of-the-line rejects.
Cathy Chhour

Cathy Chhour

Sr. Specialist, Regulatory Affairs

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客
    Bettine Boltres presents at PDA Webinar

    八月 24, 2020

    How to Include Elastomers in the Nitrosamine Risk Assessment

    Bettine Boltres

    Dr. Bettine Boltres

    Principal Scientific Affairs, Packaging & Delivery Systems

    By Your Side for Collaboration

    七月 24, 2019

    Scientific Insight Enables Risk Mitigation: Why West is By our Customers’ Side

    Fran DeGrazio

    Fran DeGrazio

    Vice President, Technical Services & Scientific Affairs

    West logo with Diamond

    三月 12, 2012

    Managing Total Cost of Ownership in a Changing Market

    West Author Logo

    Fran DeGrazio

    VP, Scientific Affairs & Technical Services